Marco Rubio & Gilead Sciences

Marco Rubio: US Secretary of State Marco Rubio expressed concern about the Ebola situation and mentioned US funds would help open 50 clinics.

Gilead Sciences: Gilead Sciences is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.

Marco Rubio: Marco Rubio, U.S. Secretary of State, stated that the administration would 'lean into' Ebola response efforts, prioritizing funding for 50 emergency clinics in affected areas and pledging $23 million.

Gilead Sciences: Gilead Sciences' antiviral drug remdesivir and experimental drug obeldesivir are being prioritized for clinical trials to treat or prevent the Bundibugyo ebolavirus, indicating its significant role in potential therapies.

Marco Rubio: Marco Rubio>>>, as Secretary of State, reiterated the United States>>>'s priority to prevent Ebola from entering the country and discussed the outbreak and U.S. support efforts with Kenyan President William Ruto.

Gilead Sciences: Gilead Sciences' antiviral remdesivir is mentioned as a potential treatment to be used at the quarantine facility, indicating its role in the medical response to Ebola.